| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.002 |